RE: Lung cancer mortality from radon versus mortality from

["Jacobus, John (OD/ORS)" <jacobusj@ors.od.nih.gov>]

Howard,

As a physician, you should know what brachytherapy and stents are.  If you need help, let me know.

-- John

John Jacobus, MS
Certified Health Physicist
3050 Traymore Lane
Bowie, MD  20715-2024

E-mail:  jenday1@email.msn.com (H)     

-----Original Message-----
From: hflong@postoffice.pacbell.net [mailto:hflong@postoffice.pacbell.net]
Sent: Tuesday, January 29, 2002 1:28 PM
To: BLHamrick@AOL.COM; radsafe@list.vanderbilt.edu
Subject: Re: Lung cancer mortality from radon versus mortality from

 . . .

Thanks for noticing that this physician relates threshold for one medicine (radiation) to the usual deadliness of overdosing ANY medicine having low dose benefit (a Lethal Dose with 50% mortality rate).

Brachytherapy for prostate cancer is destructive, above threshold locally. However, radioactive stent inhibition of endothelial overgrowth may be below threshold, like radiation treatment to inhibit skin keloid (scar overgrowth). Is the term "brachytherapy" used for stents?

 . . .